NewGenIvf Income Statement (2022-2025) | NIVF

Income Statement Dec2022 Dec2023 Sep2024 Dec2024 Jun2025 Sep2025 Dec2025
Revenue & cost
Revenue (Quarter) 1.47M1.27M1.28M1.42M
Cost of Revenue (Quarter) 0.82M-2.67M1.16M-1.68M
Gross Profit (Quarter) 0.65M0.54M0.12M0.52M
Operating items
Selling, General & Administrative (Quarter) 3.95M16.18M
Other Operating Expenses (Quarter) -0.43M0.40M-2.63M-9.38M
Operating Expenses (Quarter) -0.43M4.35M-2.63M6.80M
Operating Income (Quarter) 0.22M-1.09M-2.51M-4.97M
EBIT (Quarter) 0.22M-1.09M-2.51M-4.97M
Non-operating items
Interest & Investment Income (Quarter) -0.01M0.00M409.00248.00
Non Operating Income (Quarter) -0.25M0.55M19.26M-2.74M
Net income details
EBT (Quarter) -0.03M-0.54M16.75M-7.72M
Profit After Tax (Quarter) -0.02M-0.11M16.82M-7.67M
Income from Non-Controlling Interests (Quarter) -0.08M0.05M-0.15M0.05M
Income from Continuing Operations (Quarter) -0.03M-0.54M16.75M-7.72M
Consolidated Net Income (Quarter) -0.03M-0.54M16.75M-7.72M
Income towards Parent Company (Quarter) -0.03M-0.54M16.75M-7.72M
Net Income towards Common Stockholders (Quarter) -0.03M-0.54M16.75M-7.72M
Additional items
EPS (Basic) (Quarter) -0.01-0.00M173.09
EPS (Weighted Average and Diluted) (Quarter) -0.00M
Shares Outstanding (Weighted Average) (Quarter) 0.03M10.002.03M119.000.00M0.10M
Shares Outstanding (Diluted Average) (Quarter) 0.03M10.00119.00
EBITDA (Quarter) -0.21M-0.04M16.39M-7.57M